MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hjh.0000000000004332

Медицинская библиотека · Journal of hypertension · 2026

Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries. Part A: pathophysiology, prevalence and cardiovascular risk estimation.

Gkaliagkousi Eugenia, Lazaridis Antonios, de Ciuceis Carolina, Doumas Michael, Narkiewicz Krzysztof, Agabiti-Rosei Claudia, Anyfanti Panagiota, Malliora Anastasia, Stellos Konstantinos, Vlachogiannis Nikolaos, Stoenoiu Maria S, Stavropoulos Konstantinos, Dimitroulas Theodoros, Mavraganis Georgios, Stamatelopoulos Kimon, Terentes-Printzios Dimitrios, Ikonomidis Ignatios, Rios Francisco, Kutryb-Zając Barbara Anna, Paneni Francesco, Mengozzi Alessandro, Nosalski Ryszard, Georgiopoulos Georgios, Pavlidis George, Tual-Chalot Simon, Camargo Livia, Cappelli Federica, Dąbrowska Edyta, Quarti-Trevano Fosca, Hellmann Marcin, Masi Stefano, Montezano Augusto, Winklewski Pawel, Wolf Jacek, Costantino Sarah, Drenjančević Ines, Taddei Stefano, Guzik Tomasz, Kreutz Reinhold, Delles Christian, Touyz Rhian, Persu Alexandre, Weber Thomas, Viigimaa Margus, Grassi Guido, Virdis Agostino

СтатьяОбзорConsensus StatementПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Autoimmune rheumatic diseases (ARDs) are characterized by excessive immune system dysregulation and a significant inflammatory milieu that provokes multiorgan damage. Inflammation holds a key role in the pathophysiology of cardiovascular disease (CVD), thereby explaining the increased cardiovascular risk of patients with ARDs. Among all cardiovascular risk factors, hypertension is the most prevalent one in patients with ARDs. The pathogenesis of hypertension in ARDs is multifactorial and the result of a complex interplay between several traditional cardiovascular risk factors, the sympathetic nervous system, autoimmune disease specific factors and genetic predisposition. Importantly, even though patients with ARDs and hypertension suffer a markedly increased cardiovascular risk, current guidelines lack a widely accepted risk prediction tool to accurately estimate CVD risk and provide a highly individualized approach. This review aims to analyse the prevalence and pathophysiology of hypertension in patients with ARDs and provide an overview of cardiovascular risk assessment in this high-risk group.

Для цитирования: Gkaliagkousi Eugenia, Lazaridis Antonios, de Ciuceis Carolina, Doumas Michael, Narkiewicz Krzysztof, Agabiti-Rosei Claudia, Anyfanti Panagiota, Malliora Anastasia, Stellos Konstantinos, Vlachogiannis Nikolaos, Stoenoiu Maria S, Stavropoulos Konstantinos, Dimitroulas Theodoros, Mavraganis Georgios, Stamatelopoulos Kimon, Terentes-Printzios Dimitrios, Ikonomidis Ignatios, Rios Francisco, Kutryb-Zając Barbara Anna, Paneni Francesco, Mengozzi Alessandro, Nosalski Ryszard, Georgiopoulos Georgios, Pavlidis George, Tual-Chalot Simon, Camargo Livia, Cappelli Federica, Dąbrowska Edyta, Quarti-Trevano Fosca, Hellmann Marcin, Masi Stefano, Montezano Augusto, Winklewski Pawel, Wolf Jacek, Costantino Sarah, Drenjančević Ines, Taddei Stefano, Guzik Tomasz, Kreutz Reinhold, Delles Christian, Touyz Rhian, Persu Alexandre, Weber Thomas, Viigimaa Margus, Grassi Guido, Virdis Agostino. Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries. Part A: pathophysiology, prevalence and cardiovascular risk estimation.. Journal of hypertension. 2026. DOI: 10.1097/hjh.0000000000004332.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.